EYESOL
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79437096
- Mark type
- Stylized text
- Filed
- 22 Oct 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Liquid pharmaceutical preparations for ophthalmic use, containing at least one pharmacologically active ingredient, for the treatment of ophthalmic diseases, namely, diseases of the anterior and posterior segment of the eye
Owner
- Novaliq GmbH, DE
- Novaliq GmbH, DE
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2026 — ASSIGNED TO EXAMINER
- 25 Feb 2026 — REQUEST FOR SPECIAL HANDLING - GRANTED
- 24 Feb 2026 — ASSIGNED TO PETITION STAFF
- 04 Feb 2026 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 04 Feb 2026 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 04 Feb 2026 — TEAS REQUEST TO MAKE SPECIAL RECEIVED
- 17 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2025 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB